
Novo Nordisk's Partnering Priorities
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our primary strategic focus is in obesity, diabetes, and the related cardiometabolic diseases that impact these patients, including CVD, MASH and CKD, and rare blood disorders. In these areas, we are pioneering innovation, expanding access to our medicines, and working to prevent and ultimately cure disease.
We are looking for partners across all development stages to join us in this mission – with novel targets, new mechanisms of action or potentially disease-modifying compounds that can change the lives of people living with a serious chronic disease.
Tamara Darsow
Group Vice President, Global Business Development at Novo Nordisk
"Sharing the same dedication to getting innovation into the hands of millions of people living with obesity, diabetes and their related comorbidities, can unlock great potential. This is how we approach partnerships – committed, collaborative, leveraging each partner’s complementary capabilities."
Log in to BIO Partnering™ to send us a meeting request.

Wimal Kapadia
Vice President, Search, Evaluation & Intelligence
Zaki Salanti
Scientific Advisor
Hong Chen
Director, Search & Evaluation (USA East)
Atul Jain
Director, Search & Evaluation (USA West)
Jenny Yang
Director, Search & Evaluation (Asia Pacific)
Eva Dahlen
Director, Search & Evaluation
Carlota Sancho
Director, Search & Evaluation
Hsin-Pei Shih
Director, Search & Evaluation
Sam Bennett
Associate Director, Search & Evaluation
Ryan Beltramini
Sr. Director, Business Development
Dakota Campbell
Director, Business Development and M&A
Madeline Fitzgerald
Associate Director, Business Development
Joe Festa
Sr. Manager, BD Transactions
Mark Kohn
Director, R&D External Innovation
Ja Young Kim-Muller
Associate Scientist Director, R&D External Innovation
Joshua Jacob
Digital Intelligence Director
Stephen Buckley
Sr. Scientific Director, Drug Product Research
Lars Linderoth
Sr. Director, Peptide Research
Bharat Mani
Scientific Director, Diabetes & Obesity Metabolic Research




